Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection

Aliment Pharmacol Ther. 2017 Feb;45(4):572-573. doi: 10.1111/apt.13881.

Authors

M Zamani¹, J Shokri-Shirvani², V Zamani³

Affiliations

¹ Student Research Committee, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
² Department of Internal Medicine, Rohani Hospital, Babol University of Medical Sciences, Babol, Iran.
³ Vice-Chancellery for Health, Babol University of Medical Sciences, Babol, Iran.

PMID: 28074507
DOI: 10.1111/apt.13881

No abstract available

Publication types

Letter
Comment

MeSH terms

Amoxicillin
Anti-Bacterial Agents
Clarithromycin
Drug Resistance, Bacterial
Drug Therapy, Combination
Helicobacter Infections
Helicobacter pylori*
Humans
Levofloxacin*
Ofloxacin

Substances

Anti-Bacterial Agents
Levofloxacin
Amoxicillin
Ofloxacin
Clarithromycin